› 4wme

X-ray diffraction
1.55Å resolution

Crystal structure of catalytically inactive MERS-CoV 3CL Protease (C148A) in spacegroup C2

Released:
DOI: 10.2210/pdb4wme/pdb
PDB entry 4wme coloured by chain, front view.
PDB entry 4wme coloured by chain, side view.
PDB entry 4wme coloured by chain, top view.
Source organism: Middle East respiratory syndrome-related coronavirus
Primary publication:
Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
Needle D, Lountos GT, Waugh DS
Acta Crystallogr D Biol Crystallogr 71 1102-11 (2015)
PMID: 25945576

Function and Biology Details

Reaction catalysed: 
Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
homo dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-197770 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
ORF1a Chains: A, B, C, D
Molecule details ›
Chains: A, B, C, D
Length: 306 amino acids
Theoretical weight: 33.32 KDa
Source organism: Middle East respiratory syndrome-related coronavirus
Expression system: Escherichia coli
UniProt:
  • Canonical: W6A941 (Residues: 3248-3553; Coverage: 7%)
Sequence domains: Coronavirus endopeptidase C30
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand EDO 18 x EDO
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: APS BEAMLINE 22-BM
Spacegroup: C2
Unit cell:
a: 131.695Å b: 91.447Å c: 120.339Å
α: 90° β: 106.64° γ: 90°
R-values:
R R work R free
0.187 0.185 0.216
Expression system: Escherichia coli

Quick links

Citations

12 review citations

Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Gasmi et al. (2020)
11 more

9 mentions without citation

Repositioning microbial biotechnology against COVID-19: the case of microbial production of flavonoids.
Goris et al. (2021)
8 more